Diabetes at both baseline and follow-up was defined as 2-h glucose ≥200 mg/dl according to the 1985 World Health Organization criteria (17). Participants who reported taking hypoglycemic medication were assumed to have type 2 diabetes regardless of OGTT results. Individuals with diabetes at baseline were excluded.